Neuronetics Inc Asset Resilience Ratio
Neuronetics Inc asset resilience ratio. Neuronetics Inc (STIM) has an Asset Resilience Ratio of 0.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Neuronetics Inc (STIM) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Neuronetics Inc (2019–2025)
Asset resilience ratio of Neuronetics Inc from 2019 to 2025. This chart shows how Neuronetics Inc's Asset Resilience Ratio has changed over time. Read STIM current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Neuronetics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see STIM total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $257.00K | 0.2% |
| Total Liquid Assets | $257.00K | 0.20% |
Asset Resilience Insights
- Limited Liquidity: Neuronetics Inc maintains only 0.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neuronetics Inc Industry Peers by Asset Resilience Ratio
Compare Neuronetics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Neuronetics Inc Asset Resilience Ratio by Year (2019–2025)
Neuronetics Inc asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Neuronetics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.16% | $225.00K | $141.55 Million | +0.01pp |
| 2024-12-31 | 0.15% | $206.00K | $140.90 Million | -0.64pp |
| 2023-12-31 | 0.78% | $905.00K | $115.83 Million | -0.53pp |
| 2022-12-31 | 1.32% | $1.54 Million | $116.88 Million | -0.24pp |
| 2021-12-31 | 1.56% | $2.20 Million | $141.22 Million | -0.84pp |
| 2020-12-31 | 2.40% | $1.89 Million | $78.66 Million | +1.52pp |
| 2019-12-31 | 0.88% | $880.00K | $100.17 Million | -- |
About Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a p… Read more